Literature DB >> 1173752

In vivo cytogenetic investigations in bone marrow cells of rats, Chinese hamsters and mice treated with 6-mercaptopurine.

H Frohberg, M S Schencking.   

Abstract

The chromosome-damaging effect of 6-mercaptopurine (6-MP) was investigated in bone marrow cells of rats, Chinese hamsters, and mice after single intraperitoneal injections of doses from 3.125 to 250 mg/kg, and after multiple applications of 10, 25, 50, and 125 mg/kg. The optimal time of investigation after single administration in these studies was 48 hrs after treatment for all 3 species. A nearly linear dose-response relationship with a low quadratic component was observed. The "critical dose" for all 3 species was 12.5 mg 6-MP/kg. However, mice generally demonstrated the highest sensitivity to the "clastogenic" effect of 6-MP. In agreement with results of acute toxicity studies, Chinese hamsters generally were less (and rats least) sensitive than the mouse to chromosomal damage induced by higher doses of 6-MP. After repeated treatment with low doses, the chromosome-damaging effect of 6-MP was less pronounced than after one single administration of a large dose equaling the total amount of substance applied in chronic treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173752     DOI: 10.1007/bf00311274

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  24 in total

1.  CHROMOSOME ABERRATIONS IN BLOOD, BONE MARROW, AND SKIN FROM A PATIENT WITH ACUTE LEUKAEMIA TREATED WITH 6-MERCAPTOPURINE.

Authors:  B PEDERSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1964

2.  Cytogenetic effects of hycanthone in the rat.

Authors:  S Green; F M Sauro; M S Legator
Journal:  Mutat Res       Date:  1973-02       Impact factor: 2.433

3.  Recent findings concerning dose response relationship in mutagenicity testing of chemicals.

Authors:  H Frohberg; M S Schencking
Journal:  Arch Toxicol       Date:  1974-03-29       Impact factor: 5.153

4.  Chemically induced dominant-lethal mutations and cell killing mouse oocytes in the advanced stages of follicular development.

Authors:  W M Generoso; S W Huff; S K Stout
Journal:  Mutat Res       Date:  1971-04       Impact factor: 2.433

5.  [Effects of 6-mercaptopurine and azathioprine on human chromosomes in vitro].

Authors:  G Obe
Journal:  Arzneimittelforschung       Date:  1971-04

6.  The effects of cytoxan on the chromosomes of mouse bone marrow.

Authors:  P K Datta; E Schleiermacher
Journal:  Mutat Res       Date:  1969 Nov-Dec       Impact factor: 2.433

7.  Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.

Authors:  L L Bennett; P W Allan
Journal:  Cancer Res       Date:  1971-02       Impact factor: 12.701

8.  Chromosome studies on bone marrow from Chinese hamsters treated with benzodiazepine tranquillizers and cyclophosphamide.

Authors:  W Schmid; G R Staiger
Journal:  Mutat Res       Date:  1969 Jan-Feb       Impact factor: 2.433

9.  Chromosome damage and polyploidization induced in human peripheral leukocytes in vivo and in vitro with nitrogen mustard, 6-mercaptopurine, and A-649.

Authors:  C E Nasjleti; H H Spencer
Journal:  Cancer Res       Date:  1966-12       Impact factor: 12.701

10.  Leukocytes cultured from small inocula of whole blood and the preparation of metaphase chromosomes by treatment with hypotonic KCl.

Authors:  D A Hungerford
Journal:  Stain Technol       Date:  1965-11
View more
  3 in total

1.  Dominant lethal test in mice with 6-mercaptopurine.

Authors:  M S Schencking; H Frohberg
Journal:  Arch Toxicol       Date:  1975-09-05       Impact factor: 5.153

Review 2.  Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.

Authors:  E Gebhart
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

3.  Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems.

Authors:  L Machemer; D Lorke
Journal:  Arch Toxicol       Date:  1978-01-25       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.